Open AccessLow-Dose Ipilimumab in Combination With Nivolumab or Pembrolizumab for the Treatment of Advanced Melanoma
Author(s) -
Tara Cowling,
Heather K. Neilson,
Ransi Nayakarathna,
Quenby Mahood
Publication year - 2022
Publication title -
canadian journal of health technologies
Language(s) - English
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2022.405
Subject(s) - ipilimumab , nivolumab , pembrolizumab , medicine , retrospective cohort study , melanoma , cohort , oncology , clinical trial , cancer , immunotherapy , cancer research
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom